Hyderabad, February 25 ZeroHarm Sciences, a nano-formulated, plant-based nutraceutical brand, announced on Wednesday that it has raised ₹65 crore from Kotak Life Sciences Fund and Alkemi Growth Capital.Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I...
alkemi growth capital
consumer wellness
diagnostic testing
health platform
healthcare
hyderabad
india
investment funding
kotak life sciences fund
manufacturing
nanotechnology
nutraceuticals
plant-based supplements
r&d (research and development)
zeroharmsciences
Mumbai, February 18 Micro lender Annapurna Finance announced on Wednesday that it has raised USD 100 million through a syndicated multi-currency social loan facility.The facility is denominated in US dollars and Japanese yen, and Standard Chartered Bank acted as the sole mandated lead...